Impact of Melatonin in the Pretreatment of Organ Donor and the Influence in the Evolution of Liver Transplant.

NCT01860716 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Evidence of Liver Transplantation

Interventions

DRUG: Melatonin
DRUG: Placebo

Sponsor

Aragon Institute of Health Sciences

Collaborators

[object Object]